Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Biotron ( (AU:BIT) ) has shared an announcement.
Biotron Limited has announced details regarding its rights issue, initially disclosed on 15 October 2025. The rights issue includes an offer of one attaching option for every two shares issued, with fractions of attaching options being rounded down. The prospectus related to this rights issue will be distributed to eligible shareholders around 27 November 2025, and they are advised to review it before acquiring securities.
More about Biotron
Biotron Limited operates in the biotechnology industry, focusing on the development of novel antiviral therapies. The company is primarily engaged in research and development of drugs targeting viral infections, aiming to address significant unmet medical needs in the market.
Technical Sentiment Signal: Sell
Current Market Cap: A$6.11M
See more insights into BIT stock on TipRanks’ Stock Analysis page.